TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2013

Phase II study of lenalidomide and rituximab as salvage therapy for patients with relapsed or refractory chronic lymphocytic leukemia.

Xavier C Badoux et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.